United-Guardian (UG) Stock Price, News & Analysis

Company Overview

United-Guardian, Inc. develops, manufactures, and markets specialty chemical products for the personal care, pharmaceutical, medical, and industrial markets. The company sells its products under proprietary and customer-specific brands, and works with distributors and manufacturers in the United States and international markets.

Its personal care products include Lubrajel water-soluble gel formulations and other specialty ingredients used in skin-care, hair-care, cosmetic, and personal hygiene products. In the pharmaceutical and medical fields, United-Guardian offers products such as Renacidin and Trimo-San, which are used in specialized clinical and urological applications. The company also supplies specialty formulations for selected industrial uses.

United-Guardian is based in Hauppauge, New York, and has operated as a specialty chemical manufacturer for decades. Its business is focused on developing products with specific functional properties, obtaining the necessary regulatory approvals where applicable, and supporting customers that incorporate its formulations into finished products.

Key Stats

• Today's Range: $6.86 to $7.01
• 50-Day Range: $6.86 to $7.29
• 52-Week Range: $5.58 to $8.45
• Volume: 9,034 shs
• Average Volume: 10,178 shs
• Market Capitalization: $31.49 million
• P/E Ratio: 12.78
• Dividend Yield: 8.75%
• Price Target: N/A
• Consensus Rating: Hold

United-Guardian Stock Analysis - MarketRank™

United-Guardian scored higher than 46% of companies evaluated by MarketBeat, and ranked 612th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

United-Guardian has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

United-Guardian has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of United-Guardian is 12.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.87.

Price to Earnings Ratio vs. Sector

The P/E ratio of United-Guardian is 12.78, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 195.99.

Price to Book Value per Share Ratio

United-Guardian has a P/B Ratio of 2.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.38% of the float of United-Guardian has been sold short.

Short Interest Ratio / Days to Cover

United-Guardian has a short interest ratio ("days to cover") of 1.73, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in United-Guardian has recently decreased by 37.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

United-Guardian is a leading dividend payer. It pays a dividend yield of 8.70%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

United-Guardian has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of United-Guardian is 111.11%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.94

News Sentiment

United-Guardian has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for United-Guardian this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for UG on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added United-Guardian to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, United-Guardian insiders have not sold or bought any company stock.

Percentage Held by Insiders

29.00% of the stock of United-Guardian is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

23.16% of the stock of United-Guardian is held by institutions.

Company Calendar

• Record date for 8/4 Dividend: 7/28/2026
• Ex-Dividend for 8/4 Dividend: 7/28/2026
• Dividend Payable: 8/04/2026
• Last Earnings: 8/07/2026
• Today: 10/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:UG
• CIK: 101295
• Web: www.u-g.com
• Phone: (631) 273-0900
• Fax: 631-273-0858
• Employees: 25
• Year Founded: 1942

Profitability

• EPS (Trailing Twelve Months): $0.54
• Trailing P/E Ratio: 12.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $2.11 million
• Net Margins: 22.01%
• Pretax Margin: 27.62%
• Return on Equity: 22.24%
• Return on Assets: 19.12%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.32
• Quick Ratio: 6.64

Sales & Book Value

• Annual Sales: $10.55 million
• Price / Sales: 2.98
• Cash Flow: $0.48 per share
• Price / Cash Flow: 14.32
• Book Value: $2.44 per share
• Price / Book: 2.81

Miscellaneous

• Outstanding Shares: 4,590,000
• Free Float: 3,262,000
• Market Cap: $31.49 million
• Optionable: Not Optionable
• Beta: 0.95